Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109

9518447302
|
Calling
Whatsapp

Home/All Molecules/Ipratropium

Ipratropium Range

Comprehensive Ipratropium portfolio for Franchise & Manufacturing.

Category
ipratropium
Total Formulations
6
Available Forms
Capsule, Inhaler, Rota Cap
Featured Combinations
Browse by Form
Why Partner with Us?
About Molecule
Franchise FAQ

Expand Your Business with Our Multiple Divisions

General and OTC
Critical Care Injections
Gynae and Infertility care
Respiratory Care
Pediatric Medicines
Derma Care
Neuro care
Eye and Ear care
Ayurvedic Herbal care
Cardiac Diabetic Care
Cardiac Diabetic Care
Cardiac Diabetic Care

Browse Ipratropium portfolio by Dosage Form

Capsule
Inhaler
Rota Cap

The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Ipratropium batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Ipratropium PCD Pharma Franchise

Ipratropium PCD Pharma Franchise Company

Cafoli Lifecare is a trusted Ipratropium PCD pharma franchise company offering 6 respiratory formulations across capsule, inhaler and rotacap forms. Every batch is produced at WHO-GMP certified facilities, giving franchise partners a dependable bronchodilator range for the growing respiratory-care segment.

What is Ipratropium?

Ipratropium bromide is an inhaled anticholinergic (antimuscarinic) bronchodilator. By blocking M3 muscarinic receptors on airway smooth muscle it inhibits acetylcholine-mediated bronchoconstriction, opening the airways and reducing mucus secretion. It has a slower onset but sustained action, and is frequently combined with a beta-agonist such as levosalbutamol. Learn more on PubChem.

Therapeutic Applications of Ipratropium

Ipratropium is used for the maintenance and symptomatic relief of chronic obstructive pulmonary disease (COPD), chronic bronchitis and emphysema, and as an adjunct in acute asthma. It is prescribed mainly by pulmonologists, chest physicians, emergency physicians and general practitioners.

Why Ipratropium is a High-Potential Molecule for Distributors

India carries one of the world’s heaviest COPD and chronic respiratory disease burdens, driven by smoking and air pollution, which translates into large, recurring inhalation-therapy demand. With multiple device formats and popular fixed-dose combinations, Ipratropium offers distributors a defensible, refill-driven respiratory portfolio rather than a one-off sale.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers exclusive district-wise monopoly rights, WHO-GMP certified and DCGI-approved formulations, attractive promotional inputs and marketing support, and the reliability of a network trusted by 1000+ franchise partners across India.

References

  1. PubChem – Ipratropium Compound Summary, U.S. National Library of Medicine
  2. PubMed – Clinical literature on Ipratropium

Aceclofenac in Modern Clinical Practice

Our formulations of Ipratropium find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:

FAQ about Ipratropium in PCD Franchise

Start Your Ipratropium Franchise with Cafoli Lifecare. Partner with us for quality Ipratropium formulations backed by monopoly rights and complete promotional support. Call 9518447302 or email info@cafoli.in to book your territory today.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare offers 6 Ipratropium formulations across capsule, inhaler and rotacap forms for PCD franchise and third-party manufacturing.

Yes. Cafoli Lifecare grants exclusive district-wise monopoly rights so your respiratory territory stays protected from internal competition.

It is prescribed mainly by pulmonologists, chest physicians and general practitioners for COPD, bronchitis and asthma.

Chronic respiratory disease is widespread in India and needs long-term inhalation therapy, generating steady repeat demand, especially for combination products.

A valid Drug License and GST registration are required. On submission, Cafoli Lifecare provides your monopoly agreement and promotional inputs.

Our Manufacturing Partners

Our Manufacturing Partner | Akums Drugs and Pharmaceuticals
Our Manufacturing Partner | Pharmaceuticals Pvt. Ltd.
Our Manufacturing Partner | Tirupati
Our Manufacturing Partner | Swess-Garniers
Our Manufacturing Partner | Windlas Biotech Limited
Our Manufacturing Partner | Hetero Pharmaceutical company
Our Manufacturing Partner | Unimarck
Our Manufacturing Partner | mascort
Our Manufacturing Partner | Synokem Pharmaceuticals Limited
Our Manufacturing Partner | Biodeal Pharmaceuticals Limited